The DOM welcomes inaugural addiction medicine fellow

Substance abuse and addiction awareness initiatives

Cropsey and Gamble recipients of New NIH grant

UAB among first in US to offer new spinal cord stimulator therapy for chronic pain

Report on federal opioid programs highlights challenges with grant design, structural/policy barriers and COVID

Neuropathic pain: The underlying mechanism and a potential therapeutic target are revealed in mice

Carter accepted into the Center for Underrepresented Research in Addiction program

UAB and Diamond Therapeutics, Inc., launch psilocybin clinical trial

Chronic pain-induced depression: Underlying mechanism revealed in mice, showing how ketamine acts as antidepressant in chronic pain

Fogger co-edits addictions nursing resource

Aroke receives FNINR Protégé Award

Eaton selected as NAM Emerging Leader in Health and Medicine Scholar

PhD student receives NIH R36 grant

Eaton and Subramaniam selected to 2022 class of Women Who Shape the State

UAB researcher earns McKnight grant to study underpinnings of addiction

ZAMBAMA grant leverages “reverse innovation” to reduce unhealthy alcohol use and improve HIV outcomes

UAB researcher granted federal funding for psilocybin and smoking study

ZAMBAMA grant leverages ‘reverse innovation’ to reduce unhealthy alcohol use and improve HIV outcomes

$100 million in contributions to transform UAB School of Medicine

Links between alcohol and suicide risk to be studied

Perseverance powers Eaton’s research linking HIV, substance use and mental health

UAB team investigates suicide, opioid prescription changes

Chronotypes and cigarettes: New study explores strategies to help ethnic minorities get better rest and quit smoking

Project aims to address HIV and substance use in Jefferson County youth

New addiction and pain prevention center aims to rally researchers and community

A complex gene program initiates brain changes in response to cocaine

Discoveries on deck: Helping vulnerable patients quit smoking